Sleep apnea 'does not cause cancer'
8/05/2014
Previous research has suggested that sleep apnea may be linked to cancer development. This is challenged by a new, large study, which finds no significant association.
3-in-1 optical skin cancer probe
8/05/2014
As thousands of vacationers hit the beach this summer, many of them will expose their unprotected bare limbs to direct UV sunlight, potentially putting them at risk of skin cancer later in life.
Weakness of leukaemic stem cells discovered
8/05/2014
Despite improved therapy, only one out of every two adult patients survive acute myeloid leukaemia (AML).
New blood cancer injection given green light by regulators
8/05/2014
Patients with one of the most common forms of blood cancer4 can now benefit from a new injection.
Molecular structure reveals how a protein reads RNAs to preserve stem cell identity
8/05/2014
Every once in a while, we are forced to sort that stack of papers on the kitchen counter.
Self-assembling anti-cancer molecules created in minutes, like a self-assembling 'Lego Death Star'
8/05/2014
Researchers have developed a simple and versatile method for making artificial anti-cancer molecules that mimic the properties of one of the body's natural defence systems.
CHARGE, a rare developmental disorder, linked to tumor-suppressing protein
8/05/2014
CHARGE, which affects 1 in 10,000 babies, is an acronym whose letters stand for some of the more common symptoms of the condition: coloboma of the eye, heart defects, atresia of the choanae...
Asian-American breast cancer survivors benefit from expressive writing
8/05/2014
Writing down fears, emotions and the benefits of a cancer diagnosis may improve health outcomes for Asian-American breast cancer survivors, according to a study conducted by a researcher at the...
How DNA avoids damage from UV light
8/05/2014
In the same week that the U.S. surgeon general issued a 101-page report about the dangers of skin cancer, researchers at Montana State University published a paper breaking new ground on how DNA ...
GlaxoSmithKline's HPV vaccine: Sustained efficacy, immunogenicity and safety
8/05/2014
A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix.